EMERALD ADVISERS, LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q1 2023$8,361,742
-61.4%
237,617
-49.7%
0.40%
-61.7%
Q4 2022$21,641,244
+31.1%
472,310
+38.7%
1.05%
+22.9%
Q3 2022$16,503,000
+191.1%
340,610
+136.0%
0.85%
+191.4%
Q2 2022$5,670,000144,3100.29%
Other shareholders
CYTOKINETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BVF INC/IL 4,989,218$47,348,00010.09%
EcoR1 Capital, LLC 2,139,697$20,306,0008.01%
Healthcare Value Capital, LLC 100,000$949,0001.15%
DAFNA Capital Management LLC 150,000$1,424,0001.13%
IRONWOOD INVESTMENT MANAGEMENT LLC 151,106$1,434,0001.07%
Avoro Capital Advisors LLC 503,900$4,782,0001.06%
ACUTA CAPITAL PARTNERS, LLC 140,969$1,338,0000.64%
Iguana Healthcare Management, LLC 150,000$1,424,0000.58%
WASATCH ADVISORS LP 1,746,096$16,570,0000.25%
Virtus ETF Advisers LLC 29,379$279,0000.21%
View complete list of CYTOKINETICS INC shareholders